Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Status of and cost of Chagas disease worldwide.

Literature DB >> 23395247

Status of and cost of Chagas disease worldwide.

Gabriel Schmuñis¹.
1. gabriel.schmunis@gmail.com

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 23395247 DOI： 10.1016/S1473-3099(13)70032-X

Source DB: PubMed Journal: Lancet Infect Dis ISSN： 1473-3099 Impact factor: 25.071

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

Review 1. The IP₃ receptor and Ca²⁺ signaling in trypanosomes.

Authors: Roberto Docampo; Guozhong Huang
Journal: Biochim Biophys Acta Mol Cell Res Date: 2021-01-06 Impact factor: 4.739

2. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).

Authors: Maite Vallejo; Pedro Pa Reyes; Mireya Martinez Garcia; Alejandro G Gonzalez Garay
Journal: Cochrane Database Syst Rev Date: 2020-12-11

3. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.

Authors: Fernando J Sánchez-Valdéz; Cecilia Pérez Brandán; Galia Ramírez; Alejandro D Uncos; M Paola Zago; Rubén O Cimino; Rubén M Cardozo; Jorge D Marco; Arturo Ferreira; Miguel Ángel Basombrío
Journal: PLoS Negl Trop Dis Date: 2014-02-13

Status of and cost of Chagas disease worldwide.

Review 1. The IP₃ receptor and Ca²⁺ signaling in trypanosomes.

2. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).

3. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.

4. Mortality due to Chagas disease in Brazil according to a specific cause.

5. Trypanosoma cruzi: Time for International Recognition as a Foodborne Parasite.

6. Transcriptional and phenotypical heterogeneity of Trypanosoma cruzi cell populations.

7. Trypanosoma cruzi and Toxoplasma gondii Induce a Differential MicroRNA Profile in Human Placental Explants.

Status of and cost of Chagas disease worldwide.

Review 1. The IP3 receptor and Ca2+ signaling in trypanosomes.

2. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).

3. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.

4. Mortality due to Chagas disease in Brazil according to a specific cause.

5. Trypanosoma cruzi: Time for International Recognition as a Foodborne Parasite.

6. Transcriptional and phenotypical heterogeneity of Trypanosoma cruzi cell populations.

7. Trypanosoma cruzi and Toxoplasma gondii Induce a Differential MicroRNA Profile in Human Placental Explants.

Review 1. The IP₃ receptor and Ca²⁺ signaling in trypanosomes.